C-reactive protein, inflammation, and coronary risk

Med Clin North Am. 2000 Jan;84(1):149-61, ix. doi: 10.1016/s0025-7125(05)70211-x.


Data have revealed interactions between baseline concentration of hs-CRP and the efficacy of common pharmacologic therapies in primary and secondary prevention, suggesting not only that it may be possible to modify the increased risk associated with elevated hs-CRP, but also that inflammatory markers may be useful in targeting preventive therapies. Inflammatory markers may become a valuable component of routine cardiovascular risk assessment.

Publication types

  • Review

MeSH terms

  • C-Reactive Protein / metabolism*
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / etiology*
  • Coronary Artery Disease / prevention & control
  • Humans
  • Inflammation / complications*
  • Inflammation / diagnosis
  • Inflammation Mediators / blood
  • Myocardial Infarction / diagnosis
  • Myocardial Infarction / etiology*
  • Myocardial Infarction / prevention & control
  • Recurrence
  • Risk Factors
  • Sensitivity and Specificity


  • Inflammation Mediators
  • C-Reactive Protein